Last $75.55 USD
Change Today +0.41 / 0.55%
Volume 108.9K
OCR On Other Exchanges
Symbol
Exchange
New York
Stuttgart
As of 10:21 AM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

omnicare inc (OCR) Snapshot

Open
$75.14
Previous Close
$76.31
Day High
$75.68
Day Low
$75.02
52 Week High
02/10/15 - $79.70
52 Week Low
03/13/14 - $56.41
Market Cap
7.3B
Average Volume 10 Days
869.3K
EPS TTM
$2.82
Shares Outstanding
97.1M
EX-Date
03/10/15
P/E TM
26.8x
Dividend
$0.88
Dividend Yield
1.09%
Current Stock Chart for OMNICARE INC (OCR)

omnicare inc (OCR) Related Businessweek News

View More BusinessWeek News

omnicare inc (OCR) Details

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States. The company’s Long-Term Care Group segment offers pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities; and chronic care facilities and other settings. This segment also operates institutional pharmacy business serving skilled nursing and assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers; and provides monthly patient drug therapy evaluations, and assistance in compliance with state and federal regulations, as well as offers proprietary clinical and health management programs. In addition, it provides a suite of technology solutions based on its Omniview Web-based platform as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage; intravenous medications and nutrition products, respiratory therapy services, and clinical care planning services; and pharmaceutical case management services for retirees, employees, and dependents. Its Specialty Care Group segment provides specialty pharmacy and commercialization services for the biopharmaceutical industry; and provides brand support services, supply chain solutions, patient support services, and specialty pharmacy platforms. This segments specialized drugs deal primarily with drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology, and growth hormones. Omnicare, Inc. was founded in 1981 and is headquartered in Cincinnati, Ohio.

11,726 Employees
Last Reported Date: 02/25/15
Founded in 1981

omnicare inc (OCR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $924.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $506.2K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $485.3K
Compensation as of Fiscal Year 2013.

omnicare inc (OCR) Key Developments

Long Term Care Group Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Long term care group reported unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $1,185.0 million compared to $1,169.1 million a year ago. Adjusted operating income was $151.3 million compared to $160.4 million a year ago. For the year, the company reported net sales of $4,750.1 million compared to $4,627.9 million a year ago. Adjusted operating income was $632.2 million compared to $634.1 million a year ago.

Omnicare Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Records Asset Impairment Charge; Provides Earnings Guidance for 2015

Omnicare Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $1,627.938 million compared to $1,536.169 million a year ago. Operating income was $28.573 million compared to $143.574 million a year ago. Loss from continuing operations before income taxes was $13.236 million compared to income from continuing operations before income taxes $113.715 million a year ago. Loss from continuing operations was $8.749 million or $0.09 per diluted share compared to income from continuing operations $58.627 million or $0.54 per diluted share a year ago. Net loss was $6.049 million or $0.06 per diluted share compared to $83.696 million or $0.77 per diluted share a year ago. Adjusted cash earnings per diluted share from continuing operations were $0.96 compared to $0.87 a year ago. Adjusted EBITDA from continuing operations was $184.416 million compared to $171.660 million a year ago. EBITDA from continuing operations was $55.371 million compared to $170.914 million a year ago. Net cash flows from operating activities of continuing operations were $137.173 million compared to $23.528 million a year ago. For the year, the company reported net sales of $6,417.615 million compared to $6,013.398 million a year ago. Operating income was $427.313 million compared to $297.854 million a year ago. Income from continuing operations before income taxes was $297.366 million compared to $173.984 million a year ago. Income from continuing operations was $184.212 million or $1.74 per diluted share compared to $84.892 million or $0.78 per diluted share a year ago. Net income was $144.527 million or $1.36 per diluted share compared to net loss of $43.432 million or $0.39 per diluted share a year ago. Adjusted EBITDA from continuing operations was $718.127 million compared to $673.514 million a year ago. EBITDA from continuing operations was $536.056 million compared to $406.247 million a year ago. Net cash flows from operating activities of continuing operations were $491.727 million compared to $479.514 million a year ago. Adjusted net cash flows from continuing operating activities were $611.727 million compared to $499.514 million a year ago. Cash flows from continuing operating activities were $491.727 million compared to $479.514 million a year ago. The company recorded asset impairment charge of $60.211 million. For 2015, the company expected revenue to be $6.5 billion to $6.7 billion. Cash flows from operations to be $525 million to $625 million.

Specialty Care Group Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Specialty care group reported unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $442.8 million compared to $366.9 million a year ago. Adjusted operating income was $39.9 million compared to $31.24 million a year ago. For the year, the company reported net sales of $1,667.2 million compared to $1,384.0 million a year ago. Adjusted operating income was $136.9 million compared to $113.2 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCR:US $75.55 USD +0.41

OCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $83.58 USD -0.63
LifePoint Hospitals Inc $70.91 USD -0.56
MEDNAX Inc $70.10 USD -0.47
Patterson Cos Inc $50.07 USD -0.20
WESCO International Inc $67.98 USD -1.42
View Industry Companies
 

Industry Analysis

OCR

Industry Average

Valuation OCR Industry Range
Price/Earnings 44.0x
Price/Sales 1.2x
Price/Book 2.9x
Price/Cash Flow 51.3x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNICARE INC, please visit www.omnicare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.